The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low-dose pembrolizumab with chemotherapy in advanced NSCLC: A phase 3 randomized trial.
 
Nandini Menon
No Relationships to Disclose
 
Vanita Noronha
Research Funding - AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Roche India (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Minit Shah
No Relationships to Disclose
 
Aparna Sharma
No Relationships to Disclose
 
Prabhat Malik
Research Funding - AstraZeneca; BMS India; MSD
 
Anuj Gupta
No Relationships to Disclose
 
Akhil Kapoor
Research Funding - AstraZeneca (Inst); Bayer (Inst); Biocon (Inst); BMS (Inst); Eris Life Sciences (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche India (Inst)
 
Sharvari Gaikwad
No Relationships to Disclose
 
Alok Goel
No Relationships to Disclose
 
Ankush Shetake
No Relationships to Disclose
 
Supriya Goud
No Relationships to Disclose
 
Sucheta More
No Relationships to Disclose
 
Akanksha Yadav
No Relationships to Disclose
 
Srushti Shah
No Relationships to Disclose
 
Kavita Nawale
No Relationships to Disclose
 
Rajiv Kaushal
No Relationships to Disclose
 
Omshree Shetty
No Relationships to Disclose
 
Amit Janu
No Relationships to Disclose
 
Trupti Pai
No Relationships to Disclose
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); Aurigene Oncology Limited (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Biorasi Clinical Sci Pvt (Inst); Dr. Reddy's Laboratories (Inst); Fortrea (Inst); Fresenius Kabi (Inst); Hexal Pharmaceuticals (Inst); Johnson and Johnson (Inst); Jubilant Therapeutics (Inst); MSD (Inst); NATCO Pharma (Inst); Novartis (Inst); Roche (Inst); Samsung Bioepis (Inst)